- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!
The trial enrolled 1,313 RMS patients in 21 countries for two years of study.
Doug Kass shares his thoughts on Facebook, Allergan and Eli Lilly.
Other industry list-toppers included MiMedx, Cytokinetics, C.R. Bard, and Spectrum.